SCHEMBL4331503

SCHEMBL4331503

CCN1CCN(Cc2cnc3c(C(=O)Nc4ccccn4)ccc(-c4c(Cl)c(OC)cc(OC)c4Cl)c3n2)CC1.COc1cc(OC)c(Cl)c(-c2ccc(C(=O)O)c3ncc(N(C)CCN(C)C)nc23)c1Cl

nearest known ligand 0.76

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 20/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1126425 0.92 FGFR3 (0.72) FGFR3
SCHEMBL1126276 0.89 FGFR3 (0.77) FGFR3
SCHEMBL3317194 0.88 FGFR3 (0.62) FGFR3
SCHEMBL1126358 0.87 FGFR3 (1.00) FGFR3
SCHEMBL1126108 0.81 FGFR3 (0.72) FGFR3
SCHEMBL1126124 0.79 FGFR3 (0.72) FGFR3
SCHEMBL17023117 0.79 FGFR3 (0.63) FGFR3
SCHEMBL1126520 0.78 FGFR3 (0.72) FGFR3
SCHEMBL1126266 0.78 FGFR3 (1.00) FGFR3
SCHEMBL14212766 0.77 FGFR3 (0.66) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009141386-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2009-11-26 WO claimed